Source: Annual Congress 2010 - COPD: symptoms and staging
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Müllerova, N. Locantore, R. Tal-Singer, P. Jones (Uxbridge, United Kingdom; RTP, King of Prussia, United States Of America). SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles. Eur Respir J 2010; 36: Suppl. 54, 5547

Member's Comments

No comment yet.

Related content which might interest you: Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Possible cut-off values for stable or instable COPD as measured by the clinical COPD questionnaire (CCQ) Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care Year: 2011 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort Source: Eur Respir J 2013; 42: 636-646 Year: 2013 Association of testosterone level with phenotypic characteristics and long-term outcomes of men with COPD in the ECLIPSE cohort Source: Annual Congress 2011 - COPD: mechanisms and biomarker Year: 2011 External validation of the updated ADO score to predict mortality in COPD patients from the Birmingham COPD cohort Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC) Source: Eur Respir J 2002; 20: Suppl. 38, 262s Year: 2002 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015